Page 4 - Kineta Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Kineta Announces Restructuring and Exploration of Strategic Alternatives

29.02.2024 - SEATTLE, Feb. 29, 2024 (GLOBE NEWSWIRE) - Kineta, Inc. (Nasdaq: KA), a clinical-stage biotechnology company focused on the development of novel immunotherapies in oncology that address cancer immune resistance, announced today that it has . Seite 1

Shawn iadonatoPauline kennyKineta incChief executive officerGeneral counselKineta chartIneta kursIneta aktie

Crude Oil Moves Higher; Best Buy Posts Upbeat Earnings - Endava (NYSE:DAVA), Best Buy Co (NYSE:BBY)

U.S. stocks traded mixed midway through trading, with the Nasdaq Composite gaining around 100 points on Thursday. The Dow traded down 0.16% to 38,884.96 while the NASDAQ rose 0.38% to 16,008.19. The S&P 500 also rose, gaining, 0.16% to 5,077.83.

United statesCity ofUnited kingdomEnveric biosciencesVertex incBest buyLiveperson incCo incCorerx incSocietal cdmo incEnveric biosciences incKineta incNasdaq compositeShake shack andStocks insiders areCheck this out

Why Butterfly Network Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Thursday s Mid-Day Session - Butterfly Network (NYSE:BFLY)

Shares of Butterfly Network, Inc. (NASDAQ: BFLY) fell sharply during Thursday’s session after the company reported mixed fourth-quarter financial results.

New jerseyUnited statesFrank slootmanPerini corporationDenise dignamSridhar ramaswamyChemours companyMatt abbottSalveen richterRenalytix plcOprah winfreyAgrify corporationRevance therapeutics incVertex incSprinklr incButterfly network inc

S&P 500 Moves Higher; Hayward Holdings Shares Jump On Upbeat Results - Enveric Biosciences (NASDAQ:ENVB), Endava (NYSE:DAVA)

U.S. stocks traded mixed toward the end of trading, with the S&P 500 gaining around 0.3% on Thursday. The Dow traded down 0.08% to 38,919.26 while the NASDAQ rose 0.53% to 16,032.35. The S&P 500 also rose, gaining, 0.30% to 5,084.84.

United statesCity ofUnited kingdomEnveric biosciencesCorerx incLiveperson incKineta incSocietal cdmo incVertex incHayward holdingsEnveric biosciences incHayward holdings incShake shack andStocks insiders areCheck this outHong kong

Kineta to Present New Preclinical Data on its Anti-VISTA Antibody KVA12123 in Acute Myeloid Leukemia at the AACR Blood Cancer Discovery Symposium

Kineta to Present New Preclinical Data on its Anti-VISTA Antibody KVA12123 in Acute Myeloid Leukemia at the AACR Blood Cancer Discovery Symposium
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesJacques bouchyThierry guillaudeuxBruce mackleAmerican association for cancer researchKineta incInvestor relations business developmentLifesci advisorsPresent new preclinical dataAcute myeloid leukemiaCancer discoveryAmerican associationCancer researchBlood cancer discovery symposiumChief scientific officerAcute myeloid